These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 2554494)

  • 1. p53: a frequent target for genetic abnormalities in lung cancer.
    Takahashi T; Nau MM; Chiba I; Birrer MJ; Rosenberg RK; Vinocour M; Levitt M; Pass H; Gazdar AF; Minna JD
    Science; 1989 Oct; 246(4929):491-4. PubMed ID: 2554494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of mutant forms of p53 oncogene in primary lung cancer.
    Iggo R; Gatter K; Bartek J; Lane D; Harris AL
    Lancet; 1990 Mar; 335(8691):675-9. PubMed ID: 1969059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer.
    Takahashi T; D'Amico D; Chiba I; Buchhagen DL; Minna JD
    J Clin Invest; 1990 Jul; 86(1):363-9. PubMed ID: 2164047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the p53 gene occur in diverse human tumour types.
    Nigro JM; Baker SJ; Preisinger AC; Jessup JM; Hostetter R; Cleary K; Bigner SH; Davidson N; Baylin S; Devilee P
    Nature; 1989 Dec; 342(6250):705-8. PubMed ID: 2531845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.
    Harbour JW; Lai SL; Whang-Peng J; Gazdar AF; Minna JD; Kaye FJ
    Science; 1988 Jul; 241(4863):353-7. PubMed ID: 2838909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.
    Menon AG; Anderson KM; Riccardi VM; Chung RY; Whaley JM; Yandell DW; Farmer GE; Freiman RN; Lee JK; Li FP
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5435-9. PubMed ID: 2142531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers.
    Konishi H; Takahashi T; Kozaki K; Yatabe Y; Mitsudomi T; Fujii Y; Sugiura T; Matsuda H; Takahashi T; Takahashi T
    Oncogene; 1998 Oct; 17(16):2095-100. PubMed ID: 9798680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity is related to p53 mutations and smoking in lung cancer.
    Zienolddiny S; Ryberg D; Arab MO; Skaug V; Haugen A
    Br J Cancer; 2001 Jan; 84(2):226-31. PubMed ID: 11161381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines.
    Kelley MJ; Nakagawa K; Steinberg SM; Mulshine JL; Kamb A; Johnson BE
    J Natl Cancer Inst; 1995 May; 87(10):756-61. PubMed ID: 7563154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.
    Konishi H; Sugiyama M; Mizuno K; Saito H; Yatabe Y; Takahashi T; Osada H; Takahashi T
    Oncogene; 2003 Mar; 22(12):1892-905. PubMed ID: 12660825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.
    Chiba I; Takahashi T; Nau MM; D'Amico D; Curiel DT; Mitsudomi T; Buchhagen DL; Carbone D; Piantadosi S; Koga H
    Oncogene; 1990 Oct; 5(10):1603-10. PubMed ID: 1979160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines.
    Cheng J; Haas M
    Mol Cell Biol; 1990 Oct; 10(10):5502-9. PubMed ID: 2144611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.
    Baker SJ; Fearon ER; Nigro JM; Hamilton SR; Preisinger AC; Jessup JM; vanTuinen P; Ledbetter DH; Barker DF; Nakamura Y; White R; Vogelstein B
    Science; 1989 Apr; 244(4901):217-21. PubMed ID: 2649981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of p53 loss in human sarcomas.
    Mulligan LM; Matlashewski GJ; Scrable HJ; Cavenee WK
    Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5863-7. PubMed ID: 2143022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [p53 alterations and chromosome 17 aberrations in non-small cell lung cancer].
    Tsuji T; Tagawa Y; Hisamatsu T; Nakamura S; Terada R; Sawai T; Yasutake T; Ayabe H
    Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():263-8. PubMed ID: 9263513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point mutation of the p53 gene resulting in splicing inhibition in small cell lung carcinoma.
    Sameshima Y; Akiyama T; Mori N; Mizoguchi H; Toyoshima K; Sugimura T; Terada M; Yokota J
    Biochem Biophys Res Commun; 1990 Dec; 173(2):697-703. PubMed ID: 2175605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.
    Bartek J; Iggo R; Gannon J; Lane DP
    Oncogene; 1990 Jun; 5(6):893-9. PubMed ID: 1694291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.